Journey Medical (DERM) Up as FDA Accepts Skin Disease Drug NDA [Yahoo! Finance]
Journey Medical Corporation (DERM)
Last journey medical corporation earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.dermira.com
Company Research
Source: Yahoo! Finance
candidate, DFD-29 capsules (40mg), to treat inflammatory lesions and erythema of rosacea in adults, has been accepted by the FDA for review. A decision from the regulatory body is expected on Nov 4, 2024. The NDA submission was based on positive data from Journey Medical's two phase III studies (MVOR-1 and MVOR-2) of DFD-29 for treating rosacea. Both studies achieved the co-primary and all secondary endpoints, demonstrating statistically superior efficacy of DFD-29 over Oracea (standard of care) and placebo, as well as reduced total inflammatory lesion count. Oracea capsules are used to treat inflammation associated with rosacea in adults. In the past year, shares of DERM have surged 150.5% against the industry's 4.7% decline. Image Source: Zacks Investment Research The late-stage studies also demonstrated the beneficial effect of DFD-29 on erythema (redness) assessment, a key secondary endpoint of both studies. Erythema is an important sign of rosacea severity. Improving er
Show less
Read more
Impact Snapshot
Event Time:
DERM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DERM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DERM alerts
High impacting Journey Medical Corporation news events
Weekly update
A roundup of the hottest topics
DERM
News
- Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 [Yahoo! Finance]Yahoo! Finance
- Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024GlobeNewswire
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaGlobeNewswire
DERM
Earnings
- 11/7/23 - Beat
DERM
Sec Filings
- 3/29/24 - Form 10-K
- 3/27/24 - Form 4
- 3/25/24 - Form 4
- DERM's page on the SEC website